CSIMarket
 


Pmv Pharmaceuticals Inc   (PMVP)
Other Ticker:  
 

Cumulative Pmv Pharmaceuticals Inc 's Quick Ratio for Trailing Twelve Months Period

PMVP's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

PMVP Quick Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth -8.06 % 0.56 % -9.37 % -11.35 % 36.12 %
Y / Y Cash & cash equivalent Growth -22 % -32.57 % -18.93 % -18.88 % -15.86 %
Quick Ratio for Trailing Twelve Months Period 19.72 20.58 22.64 23.28 23.78
Total Ranking # 63 # 71 # 75 # 80 # 86
Seq. Current Liabilities Growth -6.39 % 8.09 % -2.23 % -7.07 % 2.4 %
Seq. Cash & cash equivalent Growth 7.93 % -18.46 % -4.82 % -6.88 % -6.7 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Despite year on year decrease in Pmv Pharmaceuticals Inc 's average Current Liabilities to $11 millions, Quick Ratio for Trailing Twelve Months Period to 19.72 below company average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 37 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Pmv Pharmaceuticals Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about PMVP
Quick Ratio PMVP in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 38
Sector # 48
S&P 500 # 74


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
54.97 30.3 19.72
(Jun 30 2021)   (Sep 30 2023)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Essa Pharma inc   52.76 
Altimmune inc   51.67 
Xbiotech Inc   48.57 
Synaptogenix Inc   45.96 
Nuvation Bio Inc   45.57 
Greenwich Lifesciences Inc   42.70 
Moonlake Immunotherapeutics  38.35 
Atea Pharmaceuticals Inc   36.36 
Merrimack Pharmaceuticals Inc  36.27 
Tyra Biosciences Inc   35.99 
Rayzebio Inc   34.09 
Ars Pharmaceuticals Inc   33.99 
Acelyrin Inc   33.70 
Morphic Holding inc   31.54 
Karuna Therapeutics Inc   31.39 
Aptinyx Inc   30.75 
Cocrystal Pharma Inc   29.57 
Aprea Therapeutics Inc   28.93 
Dice Therapeutics Inc   28.90 
Design Therapeutics Inc   27.75 
Atossa Therapeutics Inc   27.49 
Imago Biosciences Inc   25.43 
Xenon Pharmaceuticals Inc   25.20 
Eliem Therapeutics Inc   25.01 
Theseus Pharmaceuticals Inc   24.50 
Terns Pharmaceuticals Inc   24.19 
Cyteir Therapeutics Inc   23.81 
Rezolute Inc   23.74 
Astria Therapeutics inc   23.71 
Eqrx Inc   23.58 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com